Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Chomienne

Showing results (51-60 of 151) with videos related to

Pageof 16
Sort By:
Lancet (London, England)|June 21, 1986
Pharmacokinetic data on very-low-dose cytarabineO Poirier, C Chomienne, S Castaigne, et al.
The Journal of Clinical Investigation|December 1, 1991
All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cellsC Chomienne, N Balitrand, P Ballerini, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1991
All trans retinoic acid in acute promyelocytic leukemiaL Degos, S Castaigne, P Fenaux, et al.
Annales De Medecine Interne|January 1, 1983
[Cutaneous necrosis of the breast: a complication of oral anticoagulant treatment]C Chomienne, B Rio, Y Pouliquen, et al.
Leukemia|December 1, 1995
In vitro treatment with retinoids or the topoisomerase inhibitor, VP-16, evidences different functional apoptotic pathways in acute promyelocytic leukemic cellsC Calabresse, S Barbey, L Venturini, et al.
In Vivo (Athens, Greece)|May 1, 1988
Discrepancy between in vitro and in vivo passaged U-937 human leukemic cells: tumorigenicity and sensitivity to differentiating drugsC Chomienne, A Chedeville, N Balitrand, et al.
Leukemia|January 1, 1995
Differential uptake of all-trans retinoic acid by acute promyelocytic leukemic cells: evidence for its role in retinoic acid efficacyA Agadir, M Cornic, P Lefebvre, et al.
Leukemia|June 1, 1994
In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemiaM Cornic, L Delva, S Castaigne, et al.
Leukemia|May 29, 2010
CD44-ligation induces, through ERK1/2 pathway, synthesis of cytokines TNF-alpha and IL-6 required for differentiation of THP-1 monoblastic leukemia cellsS Bourcier, A Sansonetti, L Durand, et al.
FEBS Letters|October 30, 2001
The novel co-activator CRABPII binds to RARalpha and RXRalpha via two nuclear receptor interacting domains and does not require the AF-2 'core'J N Bastie, G Despouy, N Balitrand, et al.
Pageof 16

Showing results (51-60 of 151) with videos related to

Sort By:
Pageof 16
Lancet (London, England)|June 21, 1986
Pharmacokinetic data on very-low-dose cytarabineO Poirier, C Chomienne, S Castaigne, et al.
The Journal of Clinical Investigation|December 1, 1991
All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cellsC Chomienne, N Balitrand, P Ballerini, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1991
All trans retinoic acid in acute promyelocytic leukemiaL Degos, S Castaigne, P Fenaux, et al.
Annales De Medecine Interne|January 1, 1983
[Cutaneous necrosis of the breast: a complication of oral anticoagulant treatment]C Chomienne, B Rio, Y Pouliquen, et al.
Leukemia|December 1, 1995
In vitro treatment with retinoids or the topoisomerase inhibitor, VP-16, evidences different functional apoptotic pathways in acute promyelocytic leukemic cellsC Calabresse, S Barbey, L Venturini, et al.
In Vivo (Athens, Greece)|May 1, 1988
Discrepancy between in vitro and in vivo passaged U-937 human leukemic cells: tumorigenicity and sensitivity to differentiating drugsC Chomienne, A Chedeville, N Balitrand, et al.
Leukemia|January 1, 1995
Differential uptake of all-trans retinoic acid by acute promyelocytic leukemic cells: evidence for its role in retinoic acid efficacyA Agadir, M Cornic, P Lefebvre, et al.
Leukemia|June 1, 1994
In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemiaM Cornic, L Delva, S Castaigne, et al.
Leukemia|May 29, 2010
CD44-ligation induces, through ERK1/2 pathway, synthesis of cytokines TNF-alpha and IL-6 required for differentiation of THP-1 monoblastic leukemia cellsS Bourcier, A Sansonetti, L Durand, et al.
FEBS Letters|October 30, 2001
The novel co-activator CRABPII binds to RARalpha and RXRalpha via two nuclear receptor interacting domains and does not require the AF-2 'core'J N Bastie, G Despouy, N Balitrand, et al.
Pageof 16